Member Info for Krustysmegma

Do we call you Robin now or THEPUMA?

To be fair they've been allocated the shares if they wait 3 years. They haven't dipped into their pockets.

And the other 5.9%? Ignore it if you wish, I actually think this is good news for PXS going forward.

Over 13 million tonnes of coal exported from Port of Baltimore in 2022 apparently. Not sure if this will feed through to the POC worldwide?

1. Cyclical nature of the business.

2. Inflation/high interest rates.

3. Sector weakness in general.

Welcome comrade.

I've had my moments with him too goldeninvestor, but I actually admire the guy. He's put his money where his mouth is and always been up front about his buys, however grim they look with hindsight. He'll even admit that he's down a huge chunk. Rather him than these "I invested yesterday" merchants who appear following good news.

"On 27 March 2024 the Company learned that DSM Venturing BV's current shareholding is 130,923,358 shares, being 5.90% of the Company's existing issued share capital, and after the issue of the 45,123,732 New Provexis Shares DSM Venturing BV will hold 176,047,090 shares, which will be 7.78% of the Company's enlarged issued share capital.".

How else would you interpret that?

DSM are building a position here. Could be the precursor to a full-blown bid? Certainly one to keep an eye on.

Susi, do you have any idea how a junior biotech works? I'd say you don't , based on that post.

Closes at 12:00 noon on Tuesday 2nd April.

On a Bank Holiday weekend.

Interesting challenge for the brokers.

Surfie: "If (and ONLY if) you were a new investor this may be worth a punt at some point today but LTH's are f*cked. "

I'm a long-term holder & I assure you I'm not f*cked. I get pleasure from making money for myself and my family, which enables me to support some of the charities that have a particular significance to us, including CRUK. You, on the other hand, get pleasure from seeing other people's misery, but you yourself don't benefit from it. So, enjoy your day, I look forward to having mine.

I notice John Reader isn't participating in the fundraise. They've always presented a united front in the past when raising funds. This suggests he's not happy about something - maybe he lobbied for an earlier raise when things would have been much less painful, or he didn't want to get on board with RF perhaps? Either way, it's not good. We need them to show a united front at this stage, more than ever.

Unbelievable. Just unbelievable.

Out of interest, where does it say the managed wind-down is subject to shareholder approval?

Think I'll wait for the first set of numbers from the combined group before leaping to any conclusions. Things could be very positive going forward IMHO.

On the contrary PUMA, there are many PI's ready & willing to support a cash call from the company, should it be required. I think you'll find we're a very powerful lobby, if push comes to shove.

I don't think you need to worry about it Lfish. It won't matter which way us PI's vote, the II's will already have been consulted & will no doubt vote in favour. It's probably the safest, cheapest & easiest way to return funds to shareholders so I'll be voting in favour, just in case Schroders et al are asleep at the wheel.

Accepting you can't use discount to NAV or similar measures as a way of assessing SAR, there must be a way of valuing the opportunity. 3 or 4 years ago, the market cap was c. £200m, so effectively the market was saying there's a 20% chance of SAR being worth £1bn if the trials went well. That feels about right to me - a 1 in 5 chance of striking it rich. I suspect most LTH's invested on a similar basis having assessed the risks. However, despite only positive news in terms of progress with the current trial, the market has now discounted our chances of hitting the big time by 99%. How on earth are fledgling biotech's supposed to thrive (or even survive) in this environment? Where is the support from our Government when we need it?

In my case I'm buying back shares at less than 17p that I previously sold at the equivalent of over £3 Warty. I can't make my mind up if it's madness to keep buying with everything that's going on, or if it's madness not buying more at such a ridiculous price.

Excellent results, plus significant upgrade to 2024 forecast. Even the market can't ignore this one, significant re-rate this morning. For anyone watching MAFS Australia, Deeeeeece!